These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12847169)

  • 41. Oral anticoagulant therapy for the prevention of stroke.
    Powers WJ
    N Engl J Med; 2001 Nov; 345(20):1493-5. PubMed ID: 11794201
    [No Abstract]   [Full Text] [Related]  

  • 42. Antiphospholipid antibodies in young adults with stroke.
    Brey RL
    J Thromb Thrombolysis; 2005 Oct; 20(2):105-12. PubMed ID: 16205859
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors.
    Burke JP; Sander S; Shah H; Zarotsky V; Henk H
    Curr Med Res Opin; 2010 May; 26(5):1023-30. PubMed ID: 20199138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral Antiplatelet and Anticoagulant Agents in the Prevention and Management of Ischemic Stroke.
    Shrestha S; Coy S; Bekelis K
    Curr Pharm Des; 2017; 23(9):1377-1391. PubMed ID: 28003013
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antithrombotic medication for stroke prevention.
    Weimar C; Weber R; Diener HC
    Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1245-54. PubMed ID: 19814667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
    Lutsep HL
    J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Statin and Aspirin Pretreatment Are Associated with Lower Neurological Deterioration and Platelet Activity in Patients with Acute Ischemic Stroke.
    Yi X; Han Z; Wang C; Zhou Q; Lin J
    J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):352-359. PubMed ID: 27793535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events.
    Ringleb PA; Bhatt DL; Hirsch AT; Topol EJ; Hacke W;
    Stroke; 2004 Feb; 35(2):528-32. PubMed ID: 14739421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
    Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
    JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspirin versus low-molecular-weight heparin for ischemic stroke in children: an unanswered question.
    deVeber G; Chan A
    Stroke; 2002 Aug; 33(8):1947-8; author reply 1947-8. PubMed ID: 12154242
    [No Abstract]   [Full Text] [Related]  

  • 51. The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study.
    Radin M; Schreiber K; Cecchi I; Roccatello D; Cuadrado MJ; Sciascia S
    Eur J Neurol; 2018 Feb; 25(2):320-325. PubMed ID: 29082583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aspirin Versus Clopidogrel for Type 2 Diabetic Patients with First-Ever Noncardioembolic Acute Ischemic Stroke: Ten-Year Survival Data from the Athens Stroke Outcome Project.
    Milionis H; Ntaios G; Papavasileiou V; Spengos K; Manios E; Elisaf M; Vemmos K
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2769-2777. PubMed ID: 28756905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of antiplatelet therapy in cardiovascular disease II: Ischemic stroke.
    Cavendish JJ; Cramer SC; Graham GD
    Curr Med Res Opin; 2004 Nov; 20(11):1845-9. PubMed ID: 15537485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What are the therapeutic options for strokes secondary to intracranial large artery stenosis?
    Khan M; Kamal AK
    J Pak Med Assoc; 2011 Feb; 61(2):194-5. PubMed ID: 21375179
    [No Abstract]   [Full Text] [Related]  

  • 55. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aspirin and heparin in acute ischaemic stroke in older patients.
    Gubitz GJ; Sandercock PA
    Drugs Aging; 1999 Jul; 15(1):29-36. PubMed ID: 10459730
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Standard medical management in secondary prevention of ischemic stroke in China (SMART).
    Peng B; Zhu Y; Cui L; Ni J; Xu W; Zhou L; Yao M; Chen L; Wang J; Wang Y; Pu C;
    Int J Stroke; 2011 Oct; 6(5):461-5. PubMed ID: 21951412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience.
    Suri MF; Hussein HM; Abdelmoula MM; Divani AA; Qureshi AI
    Med Sci Monit; 2008 Oct; 14(10):PI39-44. PubMed ID: 18830204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The management of thrombosis in the antiphospholipid-antibody syndrome.
    Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
    N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prevention of ischemic stroke in middle aged patients with atrial fibrillation. Effect of sinus rhythm maintenance, aspirin, warfarin, and simvastatin].
    Kanorskiĭ SG; Shevelev VI; Zafiraki VK; Zingilevskiĭ KB
    Kardiologiia; 2007; 47(1):26-30. PubMed ID: 17426677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.